Chemistree Completes Investment in New Jersey Cannabis Applicant – ACS

VANCOUVER, July 22, 2019 /CNW/ – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that through a wholly owned U.S. subsidiary, the Company has finalized its investment into Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical vertically integrated applicant, previously announced as a letter of intent (press release dated April